The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
COPD Guidelines: A Review of the 2018 GOLD Report
Abstract
Abstract Global Strategy for the Diagnosis, Management, and Prevention of COPD 2018 is a consensus report published periodically since 2001 by an international panel of health professionals from respiratory medicine, socioeconomics, public health, and education comprising the Global Initiative for Chronic Obstructive Lung Disease (GOLD). The GOLD documents endeavor to incorporate latest evidence and expert consensus and are intended for use as “strategy documents” for implementation of effective care for chronic obstructive lung disease (COPD) on a global level. The GOLD 2018 report defines COPD as a “common, preventable and treatable disease that is characterized by persistent respiratory symptoms and airflow limitation that is due to airway and/or alveolar abnormalities, usually caused by significant exposure to noxious particles or gases,” with the criteria of “persistent respiratory symptoms” being a new and controversial inclusion since 2017. With the availability of newer pharmacotherapy options, treatment recommendations are made on the basis of a review of the latest literature and directed by symptom burden and health care utilization. Apart from the change in definition, a major shift in the recommendations is the exclusion of severity of airflow limitation as one of the major factors in guiding therapy. We review the salient features of the GOLD 2018 document and provide commentary on features that merit further discussion based on our clinical experience and practice as well as literature review current as of February 2018.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008) · Circulation · doi:10.1161/circulationaha.107.699579 · Cited by 7,491
PAUWELS, R. A., BUIST, A. S., CALVERLEY, P. M. A., JENKINS, C. R., & HURD, S. S. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.5.2101039 · Cited by 6,587
Interpretative strategies for lung function tests
Pellegrino, R., Viegi, G., Brusasco, V., Crapo, R. O., Burgos, F., Casaburi, R., Coates, A., van der Grinten, C. P. M., Gustafsson, P., Hankinson, J., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00035205 · Cited by 5,945
Quanjer, P. H., Stanojevic, S., Cole, T. J., Baur, X., Hall, G. L., Culver, B. H., Enright, P. L., Hankinson, J. L., Ip, M. S. M., Zheng, J., et al. (2012) · European Respiratory Journal · doi:10.1183/09031936.00080312 · Cited by 5,919
Spirometric Reference Values from a Sample of the General U.S. Population
HANKINSON, J. L., ODENCRANTZ, J. R., & FEDAN, K. B. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.1.9712108 · Cited by 4,206
Vogelmeier, C. F., Criner, G. J., Martinez, F. J., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Chen, R., Decramer, M., Fabbri, L. M., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201701-0218pp · Cited by 3,187
Obstructive Sleep Apnea as a Risk Factor for Stroke and Death
Yaggi, H. K., Concato, J., Kernan, W. N., Lichtman, J. H., Brass, L. M., & Mohsenin, V. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043104 · Cited by 3,004
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
Hurst, J. R., Vestbo, J., Anzueto, A., Locantore, N., Müllerova, H., Tal-Singer, R., Miller, B., Lomas, D. A., Agusti, A., MacNee, W., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909883 · Cited by 2,981
Bestall, J. C., Paul, E. A., Garrod, R., Garnham, R., Jones, P. W., & Wedzicha, J. A. (1999) · Thorax · doi:10.1136/thx.54.7.581 · Cited by 2,927
Donaldson, G. C. (2002) · Thorax · doi:10.1136/thorax.57.10.847 · Cited by 2,272
Noninvasive Ventilation for Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Brochard, L., Mancebo, J., Wysocki, M., Lofaso, F., Conti, G., Rauss, A., Simonneau, G., Benito, S., Gasparetto, A., Lemaire, F., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509283331301 · Cited by 2,057
Esteban, A. (2002) · JAMA · doi:10.1001/jama.287.3.345 · Cited by 1,779
Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD
Lipson, D. A., Barnhart, F., Brealey, N., Brooks, J., Criner, G. J., Day, N. C., Dransfield, M. T., Halpin, D. M. G., Han, M. K., Jones, C. E., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1713901 · Cited by 1,253
Azithromycin for prevention of exacerbations of COPD
Albert, R. K., Connett, J., Bailey, W. C., Casaburi, R., Cooper, J. A. D., Criner, G. J., Curtis, J. L., Dransfield, M. T., Han, M. K., Lazarus, S. C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1104623 · Cited by 1,226
Self-citationTrends in the Leading Causes of Death in the United States, 1970-2002
Jemal, A. (2005) · JAMA · doi:10.1001/jama.294.10.1255 · Cited by 987
Effect of Systemic Glucocorticoids on Exacerbations of Chronic Obstructive Pulmonary Disease
Niewoehner, D. E., Erbland, M. L., Deupree, R. H., Collins, D., Gross, N. J., Light, R. W., Anderson, P., & Morgan, N. A. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906243402502 · Cited by 875
Indacaterol–Glycopyrronium versus Salmeterol–Fluticasone for COPD
Wedzicha, J. A., Banerji, D., Chapman, K. R., Vestbo, J., Roche, N., Ayers, R. T., Thach, C., Fogel, R., Patalano, F., & Vogelmeier, C. F. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1516385 · Cited by 844
A Randomized Study of Endobronchial Valves for Advanced Emphysema
Sciurba, F. C., Ernst, A., Herth, F. J. F., Strange, C., Criner, G. J., Marquette, C. H., Kovitz, K. L., Chiacchierini, R. P., Goldin, J., & McLennan, G. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0900928 · Cited by 832
Köhnlein, T., Windisch, W., Köhler, D., Drabik, A., Geiseler, J., Hartl, S., Karg, O., Laier-Groeneveld, G., Nava, S., Schönhofer, B., et al. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70153-5 · Cited by 815
Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline
Wedzicha, J. A., Miravitlles, M., Hurst, J. R., Calverley, P. M. A., Albert, R. K., Anzueto, A., Criner, G. J., Papi, A., Rabe, K. F., Rigau, D., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00791-2016 · Cited by 683
Murphy, P. B., Rehal, S., Arbane, G., Bourke, S., Calverley, P. M. A., Crook, A. M., Dowson, L., Duffy, N., Gibson, G. J., Hughes, P. D., et al. (2017) · JAMA · doi:10.1001/jama.2017.4451 · Cited by 654
Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD
Magnussen, H., Disse, B., Rodriguez-Roisin, R., Kirsten, A., Watz, H., Tetzlaff, K., Towse, L., Finnigan, H., Dahl, R., Decramer, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1407154 · Cited by 606
Hospitalizations and Mortality in the Lung Health Study
Anthonisen, N. R., Connett, J. E., Enright, P. L., & Manfreda, J. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2110093 · Cited by 588
Chronic Obstructive Pulmonary Disease as a Risk Factor for Cardiovascular Morbidity and Mortality
Sin, D. D., & Man, S. F. P. (2005) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200404-032ms · Cited by 572
Heart Failure and Chronic Obstructive Pulmonary Disease: Diagnostic Pitfalls and Epidemiology
Hawkins, N. M., Petrie, M. C., Jhund, P. S., Chalmers, G. W., Dunn, F. G., & McMurray, J. J. V. (2009) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfn013 · Cited by 570
Miravitlles, M. (2004) · Thorax · doi:10.1136/thx.2003.008730 · Cited by 557
Ram, F. S., Picot, J., Lightowler, J., & Wedzicha, J. A. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004104.pub3 · Cited by 552
Antibiotic Treatment of Exacerbations of COPD
Stolz, D., Christ-Crain, M., Bingisser, R., Leuppi, J., Miedinger, D., Müller, C., Huber, P., Müller, B., & Tamm, M. (2007) · Chest · doi:10.1378/chest.06-1500 · Cited by 521
Austin, M. A., Wills, K. E., Blizzard, L., Walters, E. H., & Wood-Baker, R. (2010) · BMJ · doi:10.1136/bmj.c5462 · Cited by 510
Endobronchial Valves for Emphysema without Interlobar Collateral Ventilation
Klooster, K., ten Hacken, N. H. T., Hartman, J. E., Kerstjens, H. A. M., van Rikxoort, E. M., & Slebos, D.-J. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1507807 · Cited by 487
Comorbidities in Chronic Obstructive Pulmonary Disease
Chatila, W. M., Thomashow, B. M., Minai, O. A., Criner, G. J., & Make, B. J. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200709-148et · Cited by 478
Clinical and Radiologic Disease in Smokers With Normal Spirometry
Regan, E. A., Lynch, D. A., Curran-Everett, D., Curtis, J. L., Austin, J. H. M., Grenier, P. A., Kauczor, H.-U., Bailey, W. C., DeMeo, D. L., Casaburi, R. H., et al. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.2735 · Cited by 465
Depression and anxiety in patients with COPD
Yohannes, A. M., & Alexopoulos, G. S. (2014) · European Respiratory Review · doi:10.1183/09059180.00007813 · Cited by 463
Bronchiectasis, Exacerbation Indices, and Inflammation in Chronic Obstructive Pulmonary Disease
Patel, I. S., Vlahos, I., Wilkinson, T. M. A., Lloyd-Owen, S. J., Donaldson, G. C., Wilks, M., Reznek, R. H., & Wedzicha, J. A. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200305-648oc · Cited by 460
A Randomized Trial of Long-Term Oxygen for COPD with Moderate Desaturation
The Long-Term Oxygen Treatment Trial Research Group (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1604344 · Cited by 428
Antibiotics for exacerbations of chronic obstructive pulmonary disease
Vollenweider, D. J., Jarrett, H., Steurer-Stey, C. A., Garcia-Aymerich, J., & Puhan, M. A. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010257 · Cited by 425
Vestbo, J., Papi, A., Corradi, M., Blazhko, V., Montagna, I., Francisco, C., Cohuet, G., Vezzoli, S., Scuri, M., & Singh, D. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30188-5 · Cited by 425
Leuppi, J. D., Schuetz, P., Bingisser, R., Bodmer, M., Briel, M., Drescher, T., Duerring, U., Henzen, C., Leibbrandt, Y., Maier, S., et al. (2013) · JAMA · doi:10.1001/jama.2013.5023 · Cited by 424
Sleep in Chronic Obstructive Lung Disease
Flenley, D. C. (1985) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(21)00402-0 · Cited by 382
Endobronchial Valve Therapy in Patients with Homogeneous Emphysema. Results from the IMPACT Study
Valipour, A., Slebos, D.-J., Herth, F., Darwiche, K., Wagner, M., Ficker, J. H., Petermann, C., Hubner, R.-H., Stanzel, F., & Eberhardt, R. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201607-1383oc · Cited by 365
Quantitative relationships between cigarette smoking and ventilatory function.
Burrows, B. A., Knudson, R. J., Cline, M. G., & Lebowitz, M. D. (1977) · PubMed · doi:10.1164/arrd.1977.115.2.195 · Cited by 353
Martínez-García, M.-A., de la Rosa Carrillo, D., Soler-Cataluña, J.-J., Donat-Sanz, Y., Serra, P. C., Lerma, M. A., Ballestín, J., Sánchez, I. V., Selma Ferrer, M. J., Dalfo, A. R., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201208-1518oc · Cited by 340
FULFIL Trial: Once-Daily Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease
Lipson, D. A., Barnacle, H., Birk, R., Brealey, N., Locantore, N., Lomas, D. A., Ludwig-Sengpiel, A., Mohindra, R., Tabberer, M., Zhu, C.-Q., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201703-0449oc · Cited by 327
Uzun, S., Djamin, R. S., Kluytmans, J. A. J. W., Mulder, P. G. H., van't Veer, N. E., Ermens, A. A. M., Pelle, A. J., Hoogsteden, H. C., Aerts, J. G. J. V., & van der Eerden, M. M. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70019-0 · Cited by 293
Prevention of Acute Exacerbations of COPD
Criner, G. J., Bourbeau, J., Diekemper, R. L., Ouellette, D. R., Goodridge, D., Hernandez, P., Curren, K., Balter, M. S., Bhutani, M., Camp, P. G., et al. (2015) · Chest · doi:10.1378/chest.14-1676 · Cited by 288
Rennard, S. I., Calverley, P. M., Goehring, U. M., Bredenbröker, D., & Martinez, F. J. (2011) · Respiratory Research · doi:10.1186/1465-9921-12-18 · Cited by 284
Zheng, J.-P., Wen, F.-Q., Bai, C.-X., Wan, H.-Y., Kang, J., Chen, P., Yao, W.-Z., Ma, L.-J., Li, X., Raiteri, L., et al. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70286-8 · Cited by 258
Sciurba, F. C., Criner, G. J., Strange, C., Shah, P. L., Michaud, G., Connolly, T. A., Deslée, G., Tillis, W. P., Delage, A., Marquette, C.-H., et al. (2016) · JAMA · doi:10.1001/jama.2016.6261 · Cited by 242
Spirometric Criteria for Airway Obstruction
Hansen, J. E., Sun, X.-G., & Wasserman, K. (2007) · Chest · doi:10.1378/chest.06-1349 · Cited by 239
Hilde, J. M., Skjørten, I., Grøtta, O. J., Hansteen, V., Melsom, M. N., Hisdal, J., Humerfelt, S., & Steine, K. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.04.091 · Cited by 221
Ram, F., Picot, J., Lightowler, J., & Wedzicha, J. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004104.pub2 · Cited by 215
Use of blockers and the risk of death in hospitalised patients with acute exacerbations of COPD
Dransfield, M. T., Rowe, S. M., Johnson, J. E., Bailey, W. C., & Gerald, L. B. (2008) · Thorax · doi:10.1136/thx.2007.081893 · Cited by 209
The natural history of community-acquired pneumonia in COPD patients: A population database analysis
Müllerova, H., Chigbo, C., Hagan, G. W., Woodhead, M. A., Miravitlles, M., Davis, K. J., & Wedzicha, J. A. (2012) · Respiratory Medicine · doi:10.1016/j.rmed.2012.04.008 · Cited by 197
Daily physical activity in subjects with newly diagnosed COPD
Van Remoortel, H., Hornikx, M., Demeyer, H., Langer, D., Burtin, C., Decramer, M., Gosselink, R., Janssens, W., & Troosters, T. (2013) · Thorax · doi:10.1136/thoraxjnl-2013-203534 · Cited by 196
Pooler, A., & Beech, R. (2014) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s53255 · Cited by 191
Impact of Anxiety and Depression on Chronic Obstructive Pulmonary Disease Exacerbation Risk
Laurin, C., Moullec, G., Bacon, S. L., & Lavoie, K. L. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201105-0939pp · Cited by 189
Spirometry Utilization for COPD
Han, M. K., Kim, M. G., Mardon, R., Renner, P., Sullivan, S., Diette, G. B., & Martinez, F. J. (2007) · Chest · doi:10.1378/chest.06-2846 · Cited by 188
Association of Psychological Disorders With 30-Day Readmission Rates in Patients With COPD
Singh, G. K., Zhang, W., Kuo, Y., & Sharma, G. (2015) · CHEST Journal · doi:10.1378/chest.15-0449 · Cited by 182
The Prevalence of Metabolic Syndrome In Chronic Obstructive Pulmonary Disease: A Systematic Review
Cebron Lipovec, N., Beijers, R. J. H. C. G., van den Borst, B., Doehner, W., Lainscak, M., & Schols, A. M. W. J. (2016) · COPD: Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2016.1140732 · Cited by 177
Health Coaching and Chronic Obstructive Pulmonary Disease Rehospitalization: A Randomized Study
Benzo, R., Vickers, K., Novotny, P. J., Tucker, S., Hoult, J., Neuenfeldt, P., Connett, J., Lorig, K., & McEvoy, C. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201512-2503oc · Cited by 176
Struik, F. M., Lacasse, Y., Goldstein, R. S., Kerstjens, H. A. M., & Wijkstra, P. J. (2013) · Respiratory Medicine · doi:10.1016/j.rmed.2013.10.007 · Cited by 170
Chronic Obstructive Pulmonary Disease and the Risk of Stroke. The Rotterdam Study
Portegies, M. L. P., Lahousse, L., Joos, G., Albert Hofman, D., Koudstaal, P. J., Stricker, B. H. C., Brusselle, G., & Ikram, M. A. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201505-0962oc · Cited by 169
Roflumilast: a review of its use in the treatment of COPD
Wedzicha, J., Calverley, P., & Rabe, K. (2016) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s89849 · Cited by 168
Soriano, J. B., Lamprecht, B., Ramírez, A. S., Martinez-Camblor, P., Kaiser, B., Alfageme, I., Almagro, P., Casanova, C., Esteban, C., Soler-Cataluña, J. J., et al. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00157-5 · Cited by 162
Effects of written action plan adherence on COPD exacerbation recovery
Bischoff, E. W. M. A., Hamd, D. H., Sedeno, M., Benedetti, A., Schermer, T. R. J., Bernard, S., Maltais, F., & Bourbeau, J. (2011) · Thorax · doi:10.1136/thx.2009.127621 · Cited by 158
Coventry, P. A., Bower, P., Keyworth, C., Kenning, C., Knopp, J., Garrett, C., Hind, D., Malpass, A., & Dickens, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060532 · Cited by 157
The COPD Assessment Test: What Do We Know So Far?
Karloh, M., Mayer, A. F., Maurici, R., Pizzichini, M. M. M., Jones, P., & Pizzichini, E. (2015) · CHEST Journal · doi:10.1378/chest.15-1752 · Cited by 155
Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD)
Herath, S., & Poole, P. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009764.pub2 · Cited by 150
Prevalence and Localization of Pulmonary Embolism in Unexplained Acute Exacerbations of COPD
Aleva, F. E., Voets, L. W. L. M., Simons, S. O., de Mast, Q., van der Ven, A. J. A. M., & Heijdra, Y. F. (2016) · CHEST Journal · doi:10.1016/j.chest.2016.07.034 · Cited by 145
Petty, T. L. (2006) · International Journal of COPD · doi:10.2147/copd.2006.1.1.3 · Cited by 138
Wildman, M. J., Sanderson, C. F. B., Groves, J., Reeves, B. C., Ayres, J. G., Harrison, D. A., Young, D., & Rowan, K. (2007) · BMJ · doi:10.1136/bmj.39371.524271.55 · Cited by 135
(2000) · PubMed · Cited by 133
The Association Between Daytime Sleepiness and Sleep-Disordered Breathing in NREM and REM Sleep
Punjabi, N. M., Bandeen‐Roche, K., Marx, J. J., Neubauer, D. N., Smith, P. L., & Schwartz, A. R. (2002) · SLEEP · doi:10.1093/sleep/25.3.307 · Cited by 130
Procalcitonin to guide antibiotic administration in COPD exacerbations: a meta-analysis
Mathioudakis, A. G., Chatzimavridou-Grigoriadou, V., Corlăteanu, A., & Vestbo, J. (2017) · European Respiratory Review · doi:10.1183/16000617.0073-2016 · Cited by 126
Deaths Due to Cigarette Smoking for 12 Smoking-Related Cancers in the United States
Siegel, R. L., Jacobs, E. J., Newton, C. C., Feskanich, D., Freedman, N. D., Prentice, R. L., & Jemal, A. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.2398 · Cited by 125
Multicentre European study for the treatment of advanced emphysema with bronchial valves
Ninane, V., Geltner, C., Bezzi, M., Foccoli, P., Gottlieb, J., Welte, T., Seijo, L. M., Zulueta, J. J., Munavvar, M., Rosell, A., et al. (2012) · European Respiratory Journal · doi:10.1183/09031936.00019711 · Cited by 125
Conditions Associated With an Abnormal Nonspecific Pattern of Pulmonary Function Tests
Hyatt, R. E., Cowl, C. T., Bjoraker, J. A., & Scanlon, P. D. (2008) · CHEST Journal · doi:10.1378/chest.08-1235 · Cited by 125
Self-citationRoflumilast: a review of its use in the treatment of COPD
Wedzicha, J. A., Calverley, P. M. A., & Rabe, K. F. (2016) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 124
Roflumilast with long-acting β2-agonists for COPD: influence of exacerbation history
Bateman, E. D., Rabe, K. F., Calverley, P. M. A., Goehring, U.-M., Brose, M., Bredenbröker, D., & Fabbri, L. M. (2011) · European Respiratory Journal · doi:10.1183/09031936.00178710 · Cited by 120
Penalizing Hospitals for Chronic Obstructive Pulmonary Disease Readmissions
Feemster, L. C., & Au, D. H. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201308-1541pp · Cited by 119
The Nonspecific Pulmonary Function Test
Iyer, V., Schroeder, D. R., Parker, K. O., Hyatt, R. E., & Scanlon, P. D. (2010) · CHEST Journal · doi:10.1378/chest.10-0804 · Cited by 119
Self-citationJordan, R., Majothi, S., Heneghan, N. R., Blissett, D. B., Riley, R. D., Sitch, A. J., Price, M. J., Bates, E. J., Turner, A. M., Bayliss, S. E., et al. (2015) · Health Technology Assessment · doi:10.3310/hta19360 · Cited by 101
Iyer, A. S., Bhatt, S. P., Garner, J. J., Wells, J. M., Trevor, J. L., Patel, N. M., Kirkpatrick, D., Williams, J. C., & Dransfield, M. T. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201507-439oc · Cited by 99
Soler, X., Liao, S., Marín, J. M., Lorenzi‐Filho, G., Jen, R., DeYoung, P. N., Owens, R. L., Ries, A. L., & Malhotra, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177289 · Cited by 90
Jennings, J. H., Thavarajah, K., Mendez, M. P., Eichenhorn, M., Kvale, P., & Yessayan, L. (2015) · Chest · doi:10.1378/chest.14-1123 · Cited by 89
Ulrik, C. S., Ringbæk, T., Laursen, L. C., Green, A., Brøndum, E., & Frausing, E. (2015) · International Journal of COPD · doi:10.2147/copd.s85596 · Cited by 89
Gedebjerg, A., Szépligeti, S. K., Wackerhausen, L.-M. H., Horváth–Puhó, E., Dahl, R., Hansen, J. G., Sørensen, H. T., Nørgaard, M., Lange, P., & Thomsen, R. W. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30002-x · Cited by 84
[Fracture risk assessment tool].
Fujiwara, S. (2006) · PubMed · Cited by 83
Chu, D., Mehta, A., & Walkey, A. J. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix179 · Cited by 82
Beta-blockers in COPD: time for reappraisal
Lipworth, B. J., Wedzicha, J. A., Devereux, G. S., Vestbo, J., & Dransfield, M. T. (2016) · European Respiratory Journal · doi:10.1183/13993003.01847-2015 · Cited by 80
Long-term azithromycin therapy in patients with severe COPD and repeated exacerbations
Pomares, X., Montón, C., Espasa, M., Salas, J. C., Monsó, E., & Gallego, M. (2011) · International Journal of COPD · doi:10.2147/copd.s23655 · Cited by 78
López, C. C., Macario, C. C., Marín, J. M., de-Torres, J. P., Torres, R. S., González-Martín, J. M., Polverino, F., Divo, M. J., Pinto-Plata, V., Zulueta, J. J., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201707-1363oc · Cited by 73
Prevalence and risk factors for COPD in farmers: a cross-sectional controlled study
Guillien, A., Puyraveau, M., Soumagne, T., Guillot, S., Rannou, F., Marquette, D., Berger, P., Jouneau, S., Monnet, É., Mauny, F., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.00153-2015 · Cited by 70
A Self-Management Education Program Including an Action Plan for Acute COPD Exacerbations
Sedeno, M. F., Nault, D., Hamd, D. H., & Bourbeau, J. (2009) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412550903150252 · Cited by 68
E-Cigarettes and “Dripping” Among High-School Youth
Krishnan‐Sarin, S., Morean, M. E., Kong, G., Bold, K. W., Camenga, D. R., Cavallo, D. A., Simon, P., & Wu, R. (2017) · PEDIATRICS · doi:10.1542/peds.2016-3224 · Cited by 62
Azithromycin for the Prevention of COPD Exacerbations: The Good, Bad, and Ugly
Taylor, S. P., Sellers, E., & Taylor, B. (2015) · The American Journal of Medicine · doi:10.1016/j.amjmed.2015.07.032 · Cited by 60
Sleep in Chronic Obstructive Pulmonary Disease: Evidence Gaps and Challenges
Jen, R., Li, Y., Owens, R. L., & Malhotra, A. (2016) · Canadian Respiratory Journal · doi:10.1155/2016/7947198 · Cited by 46
Preventing COPD exacerbations with macrolides: A review and budget impact analysis
Simoens, S., Laekeman, G., & Decramer, M. (2013) · Respiratory Medicine · doi:10.1016/j.rmed.2012.12.019 · Cited by 44
Dretzke, J., Moore, D., Dave, C., Mukherjee, R., Price, M. J., Bayliss, S. E., Wu, X., Jordan, R. E., & Turner, A. M. (2016) · International Journal of COPD · doi:10.2147/copd.s104238 · Cited by 38
Bock, K., Bendstrup, E., Hilberg, O., & Løkke, A. (2017) · European Clinical Respiratory Journal · doi:10.1080/20018525.2017.1332931 · Cited by 38
Scott, A. S., Baltzan, M. A., & Wolkove, N. (2014) · Canadian Respiratory Journal · doi:10.1155/2014/948717 · Cited by 33
Lacasse, Y., Bernard, S., Sériès, F., Nguyen, V. H., Bourbeau, J., Aaron, S. D., & Maltais, F. (2017) · BMC Pulmonary Medicine · doi:10.1186/s12890-016-0343-9 · Cited by 33
Ebihara, S., Niu, K., Ebihara, T., Kuriyama, S., Hozawa, A., Ohmori‐Matsuda, K., Nakaya, N., Nagatomi, R., Arai, H., Kohzuki, M., et al. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00238 · Cited by 15
Bourbeau, J., Aaron, S. D., Barnes, N. C., Davis, K. J., Lacasse, Y., & Nadeau, G. A. (2016) · Respiratory Medicine · doi:10.1016/j.rmed.2016.12.015 · Cited by 15
Cited by
On-Line Analysis of Exhaled Breath: Focus Review
Bruderer, T., Gaisl, T., Gaugg, M. T., Nowak, N., Streckenbach, B., Müller, S., Moeller, A., Kohler, M., & Zenobi, R. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00005 · Cited by 278
Schmidt, M., Cattani-Cavalieri, I., Nuñez, F. J., & Ostrom, R. S. (2020) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2020.05.002 · Cited by 30
Qaisar, R., Ustrana, S., Muhammad, T., & Shah, I. (2022) · Histochemistry and Cell Biology · doi:10.1007/s00418-021-02043-3 · Cited by 21
Metadata
- Authors
- Mirza, S., Clay, R. D., Koslow, M. A., & Scanlon, P. D.
- Venue
- Mayo Clinic Proceedings
- Publisher
- Elsevier BV
- Published
- 2018-10
- Volume
- 93
- Issue
- 10
- Pages
- 1488-1502
- ISSN
- 0025-6196 (ISSN-L)
- OpenAlex
- W2894798971
- Cited by
- 444
- References
- 105
- FWCI
- 35.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.